Back to Search
Start Over
CureVac announces dosing of first participant in Phase 2 study of influenza
- Source :
- The Fly. May 28, 2024
- Publication Year :
- 2024
-
Abstract
- CureVac (CVAC) announced dosing of the first participant in a Phase 2 study of the multivalent seasonal influenza vaccine candidate developed in collaboration with GSK (GSK). The study will assess [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.795527053